Cargando…
Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence
To determine whether photobiomodulation (PBM) therapy can retard ocular axial length (AL) in children with myopia. A randomized controlled clinical trial was conducted on two consecutive cohorts of 50 eligible children aged 8–12 years with ≤ − 0.75 Diopter (D) of spherical equivalent refraction (SER...
Autores principales: | Zhou, Lei, Tong, Liyang, Li, Ying, Williams, Bruce T., Qiu, Kaikai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969012/ https://www.ncbi.nlm.nih.gov/pubmed/36849626 http://dx.doi.org/10.1038/s41598-023-30500-7 |
Ejemplares similares
-
Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study
por: Trier, Klaus, et al.
Publicado: (2008) -
Axial length growth and the risk of developing myopia in European children
por: Tideman, Jan Willem Lodewijk, et al.
Publicado: (2017) -
Intraocular epidermal growth factor concentration, axial length, and high axial myopia
por: Jonas, Jost B., et al.
Publicado: (2021) -
Axial length targets for myopia control
por: Chamberlain, Paul, et al.
Publicado: (2021) -
Pathologic myopia and severe pathologic myopia: correlation with axial length
por: Flores-Moreno, Ignacio, et al.
Publicado: (2021)